Infusion therapies are usually used as a backup treatment for people who have had an inadequate response to, or are unable to tolerate, injectable therapies for RRMS, or who are experiencing a worsening form of RRMS.
Infusion therapy is delivered by a process called intravenous (IV) infusion,
which means it is delivered directly to your bloodstream through a vein. There are 2 available infusion therapies. Both must be administered in a medical facility.
Both infusion therapies have a black box warning which you should discuss with your doctor.
Novantrone® (mitoxantrone for injection concentrate)
Tysabri® (natalizumab)
062235188/061271
Novantrone
® is a registered trademark of Serono, Inc.
Tysabri
® is a registered trademark of Elan Pharmaceuticals, Inc.